Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 1,034.00
+38.00 (3.82%)
Oct 16, 2026, 3:30 PM KST
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 189.11 billion as of October 16, 2026. It is the 22,958th most valuable company in the world and the 867th biggest in South Korea. Its market cap has decreased by 47.99% in one year.
Market Cap
189.11B
Enterprise Value
n/a
Revenue
158.79B
Global Rank
Country Rank
#867 South Korea
PE Ratio
19.33
ChartMarket Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 189.11B, an increase of 205.99%. That is a compound annual growth rate of 3.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 189.11B | -48.30% |
| Dec 30, 2025 | 365.78B | 0.60% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Huons | 201.81B |
| Hyundai Pharmaceutical | 194.30B |
| Whan In Pharm | 187.43B |
| BNC KOREA | 186.03B |
| AptaBio Therapeutics | 182.89B |
| REYON Pharmaceutical | 181.21B |
| Chong Kun Dang Holdings | 171.86B |
| FutureChem Co.,Ltd | 167.63B |